151
|
Boileve V, Schueler R, Hinojar R, Bando M, Lo Iudice F, Andersen OS, Nielsen KM, Merlo M, Dreyfus J, Attias D, Codogno I, Brochet E, Vahanian A, Messika-Zeitoun D, Kaplan S, Oeztuerk C, Weber M, Sinning JM, Welt A, Werner N, Nickenig G, Hammerstingl C, Fernandez-Golfin C, Gonzalez-Gomez A, Garcia Martin A, Casas E, Del Val D, Pardo A, Mejias A, Moya JL, Barrios V, Jimenez Nacher JJ, Zamorano JL, Yamada H, Amano R, Tamai R, Torii Y, Nishio S, Seno Y, Kusunose K, Sata M, Santoro C, Buonauro A, Ferrone M, Esposito R, Trimarco B, Petitto M, Galderisi M, Gude E, Andreassen AK, Broch K, Skulstad H, Smiseth OA, Remme EW, Damgaard DW, Jensen JM, Kraglund KL, Kim WY, Stolfo D, Gobbo M, Gabassi G, Barbati G, De Luca A, Korcova R, Secoli G, Pinamonti B, Sinagra G. Moderated Posters: A little bit of everythingP1190What causes mitral annulus dilatation-A three dimensional studyP1191Impact of interventional edge-to-edge repair with the MitraClip system on mitral valve geometry: Long-term results from a prospective single centre studyP1192Real live applications of three-dimensional echocardiographic quantification of the left atrial volumes using an automated adaptive analytics algorithmP1193Quantitative ultrasound evaluation of the changes on tissue characteristics of carotid plaques by lipid lowering therapyP1194Effort heart rate increase is an independent predictor of longitudinal function reserve in the trained heart: a stress echocardiography studyP1195Incremental value of strain imaging in classification of heart failure with normal ejection fractionP1196Multimodality work-up of young stroke patients is beneficialP1197Prognostic significance of the hemodynamic non-invasive assessment in patients with dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging 2016. [DOI: 10.1093/ehjci/jew265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
152
|
Ota T, Senaratne DNS, Preston NK, Ferrara F, Djikic D, Villemain O, Takahashi L, Niki K, Patrascu N, Benyounes N, Popa E, Diego Bellavia DB, Sundqvist M, Wei-Ting C, Papachristidis A, Djordjevic-Dikic A, Volpi C, Reis L, Nieto Tolosa J, Nishikawa H, D'angelo M, Testuz A, Mo YJ, Hashemi N, Toyota K, Nagamine K, Koide Y, Nomura T, Kurata J, Murakami Y, Kozuka Y, Ohshiro C, Thomas K, Townsend C, Wheeler S, Jacobson I, Elkington A, Balkhausen K, Bull S, Ring L, Gargani L, Carannante L, Russo V, D'alto M, Marra AM, Cittadini A, D'andrea A, Vriz O, Bossone E, Mujovic N, Dejanovic B, Peric V, Marinkovic M, Jankovic N, Orbovic B, Simic D, Sitefane F, Pernot M, Malekzadeh-Milani G, Baranger J, Bonnet D, Boudjemline Y, Uejima T, Nishikawa H, Semba H, Sawada H, Yamashita T, Sugawara M, Kayanuma H, Inoue K, Yagawa M, Takamisawa I, Umemura J, Yoshikawa T, Tomoike H, Mihalcea DJ, Mihaila S, Lungeanu L, Trasca LF, Bruja R, Neagu MS, Albu S, Cirstoiu M, Vinereanu D, Van Der Vynckt C, Gout O, Cohen A, Enache R, Jurcut R, Coman IM, Badea R, Platon P, Calin A, Beladan CC, Rosca M, Ginghina C, Popescu BA, Sonia Dell'oglio SD, Attilio Iacovoni AI, Calogero Falletta CF, Giuseppe Romano GR, Sergio Sciacca SS, Lissa Sugeng LS, Joseph Maalouf JM, Michele Pilato MP, Michele Senni MS, Cesare Scardulla CS, Francesco Clemenza FC, Salman K, Tornvall P, Ugander M, Chen ZC, Wang JJ, Fisch S, Liao RL, Roper D, Casar Demarco D, Papitsas M, Tsironis I, Byrne J, Alfakih K, Monaghan MJ, Boskovic N, Rakocevic I, Giga V, Tesic M, Stepanovic J, Nedeljkovic I, Aleksandric S, Kostic J, Beleslin B, Altman M, Annabi MS, Abouchakra L, Cucchini U, Muraru D, Badano LP, Ernande L, Derumeaux G, Teixeira R, Fernandes A, Almeida I, Dinis P, Madeira M, Ribeiro J, Puga L, Nascimento J, Goncalves L, Cambronero Sanchez FJ, Pinar Bermudez E, Gimeno Blanes JR, De La Morena Valenzuela G, Uejima T, Takahashi L, Semba H, Sawada H, Yamashita T, Lopez Fernandez T, Irazusta Cordoba FJ, Rosillo Rodriguez SO, Dominguez Melcon FJ, Meras Colunga P, Gemma D, Moreno Gomez R, Moreno Yanguela M, Lopez Sendon JL, Nguyen V, Mathieu T, Kerneis C, Cimadevilla C, Kubota N, Codogno I, Tubiana S, Estrellat C, Vahanian A, Messika-Zeitoun D, Ondrus T, Van Camp G, Di Gioia G, Barbato E, Bartunek J, Penicka M, Johnsson J, Gomez A, Alam M, Winter R. Poster Session 3The imaging examination and quality assessmentP626Value of mitral and tricuspid annular displacement to assess the interventricular systolic relationship in severe aortic valve stenosis : a Pilot studyP627Follow-up echocardiography in asymptomatic valve disease: assessing the potential economic impact of the European and American guidelines in a dedicated valve clinic, compared to standard care.P628The tricuspid valve: identification of optimal view for assessing for prolapseP629Right atrial volume by two-dimensional echocardiography in healthy subjectsP630Disturbance of inter and intra atrial conduction assessed by tissue doppler imaging in patients with medicaly controlled hypertension and prehypertension.P631Liver stiffness by shear wave elastography, new noninvasive and quantitative tool for acute variation estimation of central venous pressure in real-time?P632Weak atrial kick contribution is associated with a risk for heart failure decompensationP633Usefulness of wave intensity analysis in predicting the response to cardiac resynchronization therapyP634Early subclinical left ventricular systolic and diastolic dysfunction in gestational hypertension and preeclampsiaP635Clinical comparison of three different echocardiographic methods for left ventricular ejection fraction and LV end diastolic volume measurementP636Assessment of right ventricular-arterial coupling parameters by 3D echocardiography in patients with pulmonary hypertension receiving specific vasodilator therapyP637Prediction of right ventricular failure after left ventricular assist device implant: assessing usefulness of standard and strain echocardiographyP638Kinematic analysis of diastolic function using the novel freely available software Echo E-waves - feasibility and reproducibilityP639Evaluation of coronary flow velocity by Doppler echocardiography in the treatment of hypertension with the ARB: correlation to the histological cardiac fibrosisP640The clinical significance of limited apical ischaemia and the prognostic value of stress echocardiography - A contemporary study from a high volume centerP641Effects of intermediate stenosis of left anterior descending coronary artery on survival in patients with chronic total occlusion of right coronary arteryP642Left ventricular remodeling after a first myocardial infarction in patients with preserved ejection fraction at dischargeP643Left atrial size and acute coronary syndromes. Let is make simple.P644Influence of STEMI reperfusion strategy on systolic and diastolic functionP645Aortic valve resistance risk-stratifies low-gradient severe aortic stenosisP646Does permanent pacemaker implantation complicate the prognosis of patients after transcatheter aortic valve implantation?P647Influence of metabolic syndrome and diabetes on progression of calcific aortic valve stenosis - The COFRASA - GENERAC StudyP648Low referral for aortic valve replacement accounts for worse long-term outcome in low versus high gradient severe aortic stenosis with preserved ejection fractionP649The impact of right ventricular function from aortic valve replacement: A randomised study comparing minimally invasive aortic valve surgery and conventional open heart surgery. Eur Heart J Cardiovasc Imaging 2016. [DOI: 10.1093/ehjci/jew250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
153
|
|
154
|
Waldmann V, Milleron O, Iung B, Messika-Zeitoun D, Lepage L, Ghodbane W, Brochet E, Vahanian A, Nataf P, Jondeau G. Is Transesophageal Echocardiography Needed before Hospital Discharge in Patients after Bentall Surgery? J Am Soc Echocardiogr 2016; 30:52-58. [PMID: 27843101 DOI: 10.1016/j.echo.2016.10.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/28/2016] [Indexed: 01/16/2023]
Abstract
BACKGOUND Whether transesophageal echocardiography (TEE) should be routinely performed before hospital discharge after Bentall surgery remains unclear. The investigators took advantage of this practice at their institution to evaluate its benefit. METHODS All patients who had undergone the Bentall procedure at Bichat Hospital from January 2010 to March 2014 were included. For each patient, transthoracic echocardiographic and transesophageal echocardiographic data and clinical events were retrospectively collected from the various reports. RESULTS One hundred ninety-eight patients underwent the Bentall procedure during the study period. Postoperative TEE was performed in 117 patients (59.1%), including nine with abnormalities observed on transthoracic echocardiography (a vibrating element on the new prosthetic valve, suspicion of peritubular complications in two patients, and aortic regurgitation in six patients). In 108 patients, routine TEE was performed (i.e., without clinical indication beyond baseline postoperative imaging). Patients with and those without routine TEE were identical, except for more frequent endocarditis as an indication for surgery in patients with routine TEE. Routine TEE did not reveal any new findings that prior transthoracic echocardiography had not shown. The most frequent finding on transthoracic echocardiography or TEE was periaortic hematoma, which sometimes led to the performance of computed tomography. This imaging did not change the care of the patients in this population. CONCLUSIONS This study does not support the performance of TEE after Bentall surgery during the in-hospital course in the absence of a specific indication. Baseline postoperative imaging using TEE or computed tomography should preferably be recommended beyond the early postoperative period after periaortic hematoma has resolved.
Collapse
Affiliation(s)
| | | | - Bernard Iung
- Department of Cardiology, Bichat Hospital, Paris, France; Laboratory for Vascular Translational Science, INSERM U1148, Bichat Hospital, Paris, France; University Paris 7, Paris, France
| | - David Messika-Zeitoun
- Department of Cardiology, Bichat Hospital, Paris, France; Laboratory for Vascular Translational Science, INSERM U1148, Bichat Hospital, Paris, France; University Paris 7, Paris, France
| | - Laurent Lepage
- Department of Cardiac Surgery, Bichat Hospital, Paris, France
| | - Walid Ghodbane
- Department of Cardiac Surgery, Bichat Hospital, Paris, France
| | - Eric Brochet
- Department of Cardiology, Bichat Hospital, Paris, France
| | - Alec Vahanian
- Department of Cardiology, Bichat Hospital, Paris, France; Laboratory for Vascular Translational Science, INSERM U1148, Bichat Hospital, Paris, France; University Paris 7, Paris, France
| | - Patrick Nataf
- Laboratory for Vascular Translational Science, INSERM U1148, Bichat Hospital, Paris, France; Department of Cardiac Surgery, Bichat Hospital, Paris, France; University Paris 7, Paris, France
| | - Guillaume Jondeau
- Department of Cardiology, Bichat Hospital, Paris, France; Laboratory for Vascular Translational Science, INSERM U1148, Bichat Hospital, Paris, France; University Paris 7, Paris, France.
| |
Collapse
|
155
|
Nickenig G, Kuck KH, Baldus S, Colombo A, Alfieri O, Vahanian A, Maisano F. TCT-41 Up to two years follow up results of mitral valve transcatheter annuloplasty system for mitral reconstruction multi-center trial. J Am Coll Cardiol 2016. [DOI: 10.1016/j.jacc.2016.09.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
156
|
Shah A, Horlick E, Osten M, Kornowski R, Vahanian A, Himbert D, Napodano M, Bruschi G, Nissen H, Simonato dos Santos M, Lefevre T, Hernandez JM, Maisano F, Kasel M, Gaia D, Teles RC, Bleiziffer S, Barbanti M, Tamburino C, Colombo A, Latib A, Perpetua E, Tchetche D, Petronio A, Ferrari E, Treede H, Walther T, Rodés-Cabau J, Dvir D. TCT-652 Incidence, Predictors and Clinical Outcomes of Device Malposition Following Transcatheter Aortic Valve Implantation for Degenerative Bioprosthetic Surgical Valves: Insights from the VIVID Registry. J Am Coll Cardiol 2016. [DOI: 10.1016/j.jacc.2016.09.065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
157
|
Jilaihawi H, Chen M, Webb J, Himbert D, Ruiz CE, Rodés-Cabau J, Pache G, Colombo A, Nickenig G, Lee M, Tamburino C, Sievert H, Abramowitz Y, Tarantini G, Alqoofi F, Chakravarty T, Kashif M, Takahashi N, Kazuno Y, Maeno Y, Kawamori H, Chieffo A, Blanke P, Dvir D, Ribeiro HB, Feng Y, Zhao ZG, Sinning JM, Kliger C, Giustino G, Pajerski B, Imme S, Grube E, Leipsic J, Vahanian A, Michev I, Jelnin V, Latib A, Cheng W, Makkar R. A Bicuspid Aortic Valve Imaging Classification for the TAVR Era. JACC Cardiovasc Imaging 2016; 9:1145-1158. [DOI: 10.1016/j.jcmg.2015.12.022] [Citation(s) in RCA: 108] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/14/2015] [Revised: 11/25/2015] [Accepted: 12/10/2015] [Indexed: 10/21/2022]
|
158
|
Urena M, Himbert D, Ohlmann P, Capretti G, Goublaire C, Kindo M, Morel O, Ghodbane W, Iung B, Vahanian A. Transcatheter Aortic Valve Replacement to Treat Pure Aortic Regurgitation on Noncalcified Native Valves. J Am Coll Cardiol 2016; 68:1705-1706. [DOI: 10.1016/j.jacc.2016.07.746] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2016] [Revised: 07/09/2016] [Accepted: 07/12/2016] [Indexed: 10/20/2022]
|
159
|
Capretti G, Urena M, Himbert D, Brochet E, Goublaire C, Verdonk C, Carrasco JL, Ghodbane W, Messika-Zeitoun D, Iung B, Nataf P, Vahanian A. Valve Thrombosis After Transcatheter Mitral Valve Replacement. J Am Coll Cardiol 2016; 68:1814-1815. [DOI: 10.1016/j.jacc.2016.07.757] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/26/2016] [Revised: 07/06/2016] [Accepted: 07/12/2016] [Indexed: 11/30/2022]
|
160
|
Stehlik J, Bavaria JE, Bax J, Cronenwett JL, Edwards LB, Fairman RM, Ferrari R, Jacobs JP, Johnson MR, Kraiss LW, Masoudi FA, Mehra MR, Vahanian A, Walsh MN, Lund LH. Heart, lung, and vascular registries: Evolving goals, successful approaches, and ongoing innovation. J Heart Lung Transplant 2016; 35:1149-1157. [DOI: 10.1016/j.healun.2016.08.021] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2016] [Accepted: 08/24/2016] [Indexed: 10/21/2022] Open
|
161
|
Regueiro A, Linke A, Latib A, Ihlemann N, Urena M, Walther T, Husser O, Herrmann HC, Nombela-Franco L, Cheema AN, Le Breton H, Stortecky S, Kapadia S, Bartorelli AL, Sinning JM, Amat-Santos I, Munoz-Garcia A, Lerakis S, Gutiérrez-Ibanes E, Abdel-Wahab M, Tchetche D, Testa L, Eltchaninoff H, Livi U, Castillo JC, Jilaihawi H, Webb JG, Barbanti M, Kodali S, de Brito FS, Ribeiro HB, Miceli A, Fiorina C, Dato GMA, Rosato F, Serra V, Masson JB, Wijeysundera HC, Mangione JA, Ferreira MC, Lima VC, Carvalho LA, Abizaid A, Marino MA, Esteves V, Andrea JCM, Giannini F, Messika-Zeitoun D, Himbert D, Kim WK, Pellegrini C, Auffret V, Nietlispach F, Pilgrim T, Durand E, Lisko J, Makkar RR, Lemos PA, Leon MB, Puri R, San Roman A, Vahanian A, Søndergaard L, Mangner N, Rodés-Cabau J. Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death. JAMA 2016; 316:1083-92. [PMID: 27623462 DOI: 10.1001/jama.2016.12347] [Citation(s) in RCA: 216] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
IMPORTANCE Limited data exist on clinical characteristics and outcomes of patients who had infective endocarditis after undergoing transcatheter aortic valve replacement (TAVR). OBJECTIVE To determine the associated factors, clinical characteristics, and outcomes of patients who had infective endocarditis after TAVR. DESIGN, SETTING, AND PARTICIPANTS The Infectious Endocarditis after TAVR International Registry included patients with definite infective endocarditis after TAVR from 47 centers from Europe, North America, and South America between June 2005 and October 2015. EXPOSURE Transcatheter aortic valve replacement for incidence of infective endocarditis and infective endocarditis for in-hospital mortality. MAIN OUTCOMES AND MEASURES Infective endocarditis and in-hospital mortality after infective endocarditis. RESULTS A total of 250 cases of infective endocarditis occurred in 20 006 patients after TAVR (incidence, 1.1% per person-year; 95% CI, 1.1%-1.4%; median age, 80 years; 64% men). Median time from TAVR to infective endocarditis was 5.3 months (interquartile range [IQR], 1.5-13.4 months). The characteristics associated with higher risk of progressing to infective endocarditis after TAVR was younger age (78.9 years vs 81.8 years; hazard ratio [HR], 0.97 per year; 95% CI, 0.94-0.99), male sex (62.0% vs 49.7%; HR, 1.69; 95% CI, 1.13-2.52), diabetes mellitus (41.7% vs 30.0%; HR, 1.52; 95% CI, 1.02-2.29), and moderate to severe aortic regurgitation (22.4% vs 14.7%; HR, 2.05; 95% CI, 1.28-3.28). Health care-associated infective endocarditis was present in 52.8% (95% CI, 46.6%-59.0%) of patients. Enterococci species and Staphylococcus aureus were the most frequently isolated microorganisms (24.6%; 95% CI, 19.1%-30.1% and 23.3%; 95% CI, 17.9%-28.7%, respectively). The in-hospital mortality rate was 36% (95% CI, 30.0%-41.9%; 90 deaths; 160 survivors), and surgery was performed in 14.8% (95% CI, 10.4%-19.2%) of patients during the infective endocarditis episode. In-hospital mortality was associated with a higher logistic EuroSCORE (23.1% vs 18.6%; odds ratio [OR], 1.03 per 1% increase; 95% CI, 1.00-1.05), heart failure (59.3% vs 23.7%; OR, 3.36; 95% CI, 1.74-6.45), and acute kidney injury (67.4% vs 31.6%; OR, 2.70; 95% CI, 1.42-5.11). The 2-year mortality rate was 66.7% (95% CI, 59.0%-74.2%; 132 deaths; 115 survivors). CONCLUSIONS AND RELEVANCE Among patients undergoing TAVR, younger age, male sex, history of diabetes mellitus, and moderate to severe residual aortic regurgitation were significantly associated with an increased risk of infective endocarditis. Patients who developed endocarditis had high rates of in-hospital mortality and 2-year mortality.
Collapse
Affiliation(s)
- Ander Regueiro
- Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada
| | - Axel Linke
- Heart Center, Leipzig University, Leipzig, Germany
| | - Azeem Latib
- EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy
| | | | - Marina Urena
- Bichat Hôpital, AP-HP, University Paris Diderot, France
| | | | - Oliver Husser
- Deutsches Herzzentrum München, Technische Universität München, DZHK, partner site Munich Heart Alliance, Munich, Germany
| | | | | | | | | | - Stefan Stortecky
- Bern University Hospital (on behalf of Swiss TAVI Registry Centres), Bern, Switzerland
| | | | | | | | | | | | | | | | | | | | | | | | - Ugolino Livi
- Department of Cardiothoracic Surgery, University Hospital of Udine, Italy
| | | | | | - John G Webb
- St Pauls Hospital, Vancouver, British Columbia, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | | - Valter C Lima
- Hospital São Francisco-Santa Casa de Misericórdia de Porto Alegre, Brazil
| | | | | | | | | | | | - Francesco Giannini
- EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy
| | | | | | | | - Costanza Pellegrini
- Deutsches Herzzentrum München, Technische Universität München, DZHK, partner site Munich Heart Alliance, Munich, Germany
| | | | | | - Thomas Pilgrim
- Bern University Hospital (on behalf of Swiss TAVI Registry Centres), Bern, Switzerland
| | - Eric Durand
- Hôpital Charles Nicolle, University of Rouen, INSERM U1096, France
| | - John Lisko
- Emory University School of Medicine, Atlanta, Georgia
| | - Raj R Makkar
- Cedars-Sinai Heart Institute, Los Angeles, California
| | | | - Martin B Leon
- Columbia University Medical Center, New York, New York
| | - Rishi Puri
- Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada
| | | | - Alec Vahanian
- Bichat Hôpital, AP-HP, University Paris Diderot, France
| | | | | | - Josep Rodés-Cabau
- Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada
| |
Collapse
|
162
|
Bouleti C, Chauvet M, Franchineau G, Himbert D, Iung B, Alos B, Brochet E, Urena M, Ghodbane W, Ou P, Provenchere S, Nataf P, Vahanian A. The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome. Eur J Cardiothorac Surg 2016; 51:80-88. [PMID: 27582074 DOI: 10.1093/ejcts/ezw211] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/02/2016] [Revised: 04/29/2016] [Accepted: 05/10/2016] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVES Transcatheter aortic valve implantation (TAVI) has reoriented the treatment of aortic stenosis (AS) for high-risk patients. Little is known about late outcome after TAVI, surgical aortic valve replacement (AVR) or medical treatment in a single centre. We report patients' characteristics, early and 6-year survival rates after the three therapeutic strategies, and the evolution over time. We also analysed predictive factors of mortality after TAVI or surgical AVR. METHODS Between October 2006 and December 2010, 478 high-risk consecutive patients were referred for severe symptomatic AS. After Heart Team evaluation, 253 underwent a TAVI, 102 a surgical AVR and 123 medical treatment including 33 compassionate percutaneous balloon aortic valvuloplasties (PBAVs). Follow-up was complete in 98% of patients. RESULTS Medically treated patients had higher risk scores than the other two groups. They presented a significantly worse survival (P < 0.001), with a 1-year rate of only 30%. The 33 patients who underwent compassionate PBAV presented the lowest survival rate, even lower than patients receiving drug therapy alone. In the TAVI group, patients had more comorbidities than those in the surgical group. There was no difference in 30-day survival rates [91 ± 2% for TAVI and 88 ± 3% for surgical AVR, hazard ratio (HR) for TAVI: 1.37; 95% CI: 0.73-2.58, P = 0.32]. Predictive factors of 30-day mortality were mainly postintervention complications illustrated by higher troponin levels and infection. The 6-year survival rates were 32 ± 4 and 40 ± 6% for TAVI and surgical AVR, respectively (HR for TAVI: 0.71; 95% CI: 0.53-0.97, P = 0.03), but the difference was no longer significant after adjustment on the Charlson comorbidity index (HR: 0.94; 95% CI: 0.68-1.29, P = 0.68). Predictive factors of late mortality were patients' comorbidities for both groups and paraprosthetic aortic regurgitation ≥2/4 for the TAVI group. The number of interventions (TAVI or surgery) increases over years, driven by the number of TAVI procedures without any decrease in surgical AVR. CONCLUSIONS In this single-centre study, medically treated patients with severe AS have a higher risk profile than those undergoing surgery or TAVI. Their survival is particularly poor and not improved by compassionate PBAV. When comparing TAVI and surgical AVR, there was no difference in 30-day and 6-year survival rates after adjusting for comorbidities.
Collapse
Affiliation(s)
- Claire Bouleti
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France .,DHU Fire, Paris-Diderot University, Paris, France
| | - Marion Chauvet
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Guillaume Franchineau
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Dominique Himbert
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France.,DHU Fire, Paris-Diderot University, Paris, France.,INSERM U1148 Bichat Hospital, Paris, France
| | - Bernard Iung
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France.,DHU Fire, Paris-Diderot University, Paris, France.,INSERM U1148 Bichat Hospital, Paris, France.,Faculté de Médecine Paris-Diderot University, Paris, France
| | - Benjamin Alos
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Eric Brochet
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France.,DHU Fire, Paris-Diderot University, Paris, France
| | - Marina Urena
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France.,DHU Fire, Paris-Diderot University, Paris, France
| | - Walid Ghodbane
- Department of Cardiac Surgery, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Phalla Ou
- INSERM U1148 Bichat Hospital, Paris, France.,Faculté de Médecine Paris-Diderot University, Paris, France.,Department of Radiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Sophie Provenchere
- Department of Anaesthesiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Patrick Nataf
- DHU Fire, Paris-Diderot University, Paris, France.,Faculté de Médecine Paris-Diderot University, Paris, France.,Department of Cardiac Surgery, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Alec Vahanian
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France.,DHU Fire, Paris-Diderot University, Paris, France.,INSERM U1148 Bichat Hospital, Paris, France.,Faculté de Médecine Paris-Diderot University, Paris, France
| |
Collapse
|
163
|
Nguyen A, Urena M, Himbert D, Goublaire C, Brochet E, Gardy-Verdonk C, Carrasco JL, Ghodbane W, Nataf P, Vahanian A. Late Displacement After Transcatheter Mitral Valve Replacement for Degenerative Mitral Valve Disease With Massive Annular Calcification. JACC Cardiovasc Interv 2016; 9:1633-4. [DOI: 10.1016/j.jcin.2016.05.033] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Revised: 05/09/2016] [Accepted: 05/19/2016] [Indexed: 11/26/2022]
|
164
|
Zarka S, Bouleti C, Arangalage D, Chopra H, Chillon S, Henry-Feugeas MC, Abtan J, Juliard JM, Iung B, Vahanian A, Laissy JP, Ou P. Usefulness of Subepicardial Hyperemia on Contrast-Enhanced First-Pass Magnetic Resonance Perfusion Imaging for Diagnosis of Acute Myocarditis. Am J Cardiol 2016; 118:440-5. [PMID: 27296557 DOI: 10.1016/j.amjcard.2016.05.022] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/11/2016] [Revised: 05/04/2016] [Accepted: 05/04/2016] [Indexed: 11/16/2022]
Abstract
Hyperemia is a major criterion for the diagnosis of acute myocarditis on cardiac magnetic resonance imaging but its assessment is challenging and time consuming. We evaluated the usefulness of the contrast-enhanced first-pass perfusion (FPP) on magnetic resonance imaging for detecting subepicardial hyperemia in acute myocarditis. Forty-seven consecutive patients (mean age: 42 ± 15.6 years; 35 men) with a definite diagnosis of acute myocarditis according to the state-of-the-art guidelines were included and compared with 16 control subjects. FPP was evaluated by 2 blinded observers and compared with the reference late gadolinium enhancement. Detection of hyperemia was performed on both qualitative and quantitative methods. Relative increased signal intensity (SI) in the subepicardial hyperemic layer was measured with SI ratio (SI of the subepicardial layer/SI of the immediately adjacent subendocardial layer). Twenty-four patients (51%) with acute myocarditis exhibited subepicardial hyperemia, detected with a good interobserver reproducibility (kappa coefficient: 0.75). The SI in the myocardium of myocarditis patients was increased compared with controls (1.08 ± 0.03 vs 0.945 ± 0.04, p = 0.03) and the SI in myocarditis patients with hyperemia compared with those without hyperemia (1.22 ± 0.04 vs 0.94 ± 0.04, p <0.0001). Sensitivity, specificity, positive predictive, and negative predictive values of FPP for detecting hyperemia were 85%, 94%, 85%, and 93%, respectively. In conclusion, contrast-enhanced first-pass magnetic resonance imaging is a fast and useful method for assessing myocardial hyperemia in patients with acute myocarditis.
Collapse
Affiliation(s)
- Samuel Zarka
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Claire Bouleti
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; Paris-Diderot University, DHU FIRE, Paris, France
| | - Dimitri Arangalage
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; Paris-Diderot University, DHU FIRE, Paris, France
| | - Houzefa Chopra
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Sylvie Chillon
- Department of Radiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | | | - Jérémie Abtan
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; Paris-Diderot University, DHU FIRE, Paris, France
| | - Jean-Michel Juliard
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; Paris-Diderot University, DHU FIRE, Paris, France
| | - Bernard Iung
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; Paris-Diderot University, DHU FIRE, Paris, France
| | - Alec Vahanian
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; Paris-Diderot University, DHU FIRE, Paris, France
| | - Jean-Pierre Laissy
- Paris-Diderot University, DHU FIRE, Paris, France; Department of Radiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Phalla Ou
- Paris-Diderot University, DHU FIRE, Paris, France; Department of Radiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; INSERM U1148 Bichat Hospital, Paris, France.
| |
Collapse
|
165
|
Affiliation(s)
- Alec Vahanian
- Department of Cardiology, Bichat Hospital, University Paris VII, Paris, France
| | - Patrick Nataf
- Department of Cardiac Surgery, Bichat Hospital, University Paris VII, Paris, France
| |
Collapse
|
166
|
Abstract
Patients with multiple valve disease are a frequent and heterogeneous entity whose evaluation and management are challenging. The assessment of the severity requires a cautious integrative evaluation. The indications for intervention are based on global assessment of the consequences of the disease, mainly based on symptoms, pulmonary hypertension, and left ventricular dysfunction. The decision to intervene should also take into account the inherent additional risk. Percutaneous intervention in this population is in its infancy but the future development of transcatheter techniques will be of interest in this high-risk cohort and will offer the possibility of tailored and staged procedures.
Collapse
Affiliation(s)
- Alec Vahanian
- Cardiology Department, Bichat Hospital, University Paris VII, Paris, France
| | | | | |
Collapse
|
167
|
Arangalage D, Lepage L, Faille D, Cimadevilla C, Dilly MP, Papy E, Alhenc-Gelas M, Ghodbane W, Nataf P, Iung B, Steg PG, Vahanian A, Ajzenberg N, Messika-Zeitoun D. Presentation, management and outcome of heparin-induced thrombocytopenia after valvular heart surgery. Eur J Cardiothorac Surg 2016; 50:1132-1138. [PMID: 27301386 DOI: 10.1093/ejcts/ezw200] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/16/2016] [Revised: 05/01/2016] [Accepted: 05/04/2016] [Indexed: 12/13/2022] Open
Abstract
OBJECTIVES The use of heparin exposes patients to heparin-induced thrombocytopenia, which is a challenging issue for both diagnosis and patient management. We sought to describe the clinical presentation, management and outcome of a series of patients diagnosed with heparin-induced thrombocytopenia after heart valve surgery. METHODS All consecutive patients diagnosed with heparin-induced thrombocytopenia during the postoperative period of heart valve surgery over a 6-year period were prospectively enrolled in a single-centre registry. Clinical and biological data were collected. In-hospital and mid-term outcomes were assessed. Information regarding the occurrence of all medical events including death, recurrence of thromboembolic events and/or thrombocytopenia was collected. RESULTS We identified 93 patients (incidence proportion = 2.8%). Most patients (82%) were asymptomatic with isolated thrombocytopenia at the time of diagnosis. The other main circumstance of diagnosis was the occurrence of thromboembolic events in 17 patients (6 strokes, 10 prosthetic valve thrombosis and 1 peripheral embolic event). The in-hospital mortality rate was 1%. No thrombolysis, interventional procedure or redo surgery was performed. Danaparoid sodium was used as heparin replacement therapy in most cases (96%) and leading to complete and uneventful thrombus resolution in all cases with only one possibly related major bleeding complication. During a mean follow-up of 36 ± 20 months, no patient presented recurrence of any heparin-induced thrombocytopenia-related complication. CONCLUSIONS In this contemporary series of patients, heparin-induced thrombocytopenia incidence was low and isolated thrombocytopenia was the most frequent presentation. Conservative management with early diagnosis and substitutive anticoagulation therapy introduction was associated with a low rate of clinical events and a remarkably good outcome with a low mortality rate.
Collapse
Affiliation(s)
- Dimitri Arangalage
- Department of Cardiology, Bichat Hospital, Paris, France.,INSERM U1148, Bichat Hospital, Paris, France.,University Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine Paris-Diderot, Paris, France
| | - Laurent Lepage
- Department of Cardiac Surgery, Bichat Hospital, Paris, France
| | - Dorothée Faille
- INSERM U1148, Bichat Hospital, Paris, France.,University Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine Paris-Diderot, Paris, France.,Department of Hematology, Bichat Hospital, Paris, France
| | | | | | | | - Martine Alhenc-Gelas
- Department of Biological Hematology, European Hospital Georges Pompidou, AP-HP, Paris, France
| | - Walid Ghodbane
- Department of Cardiac Surgery, Bichat Hospital, Paris, France
| | - Patrick Nataf
- INSERM U1148, Bichat Hospital, Paris, France.,University Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine Paris-Diderot, Paris, France.,Department of Cardiac Surgery, Bichat Hospital, Paris, France
| | - Bernard Iung
- Department of Cardiology, Bichat Hospital, Paris, France.,INSERM U1148, Bichat Hospital, Paris, France.,University Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine Paris-Diderot, Paris, France
| | - Philippe Gabriel Steg
- Department of Cardiology, Bichat Hospital, Paris, France.,INSERM U1148, Bichat Hospital, Paris, France.,University Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine Paris-Diderot, Paris, France
| | - Alec Vahanian
- Department of Cardiology, Bichat Hospital, Paris, France.,INSERM U1148, Bichat Hospital, Paris, France.,University Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine Paris-Diderot, Paris, France
| | - Nadine Ajzenberg
- INSERM U1148, Bichat Hospital, Paris, France.,University Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine Paris-Diderot, Paris, France.,Department of Hematology, Bichat Hospital, Paris, France
| | - David Messika-Zeitoun
- Department of Cardiology, Bichat Hospital, Paris, France .,INSERM U1148, Bichat Hospital, Paris, France.,University Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine Paris-Diderot, Paris, France
| |
Collapse
|
168
|
Simonato M, Webb J, Kornowski R, Vahanian A, Frerker C, Nissen H, Bleiziffer S, Duncan A, Rodés-Cabau J, Attizzani GF, Horlick E, Latib A, Bekeredjian R, Barbanti M, Lefevre T, Cerillo A, Hernández JM, Bruschi G, Spargias K, Iadanza A, Brecker S, Palma JH, Finkelstein A, Abdel-Wahab M, Lemos P, Petronio AS, Champagnac D, Sinning JM, Salizzoni S, Napodano M, Fiorina C, Marzocchi A, Leon M, Dvir D. Transcatheter Replacement of Failed Bioprosthetic Valves. Circ Cardiovasc Interv 2016; 9:CIRCINTERVENTIONS.115.003651. [DOI: 10.1161/circinterventions.115.003651] [Citation(s) in RCA: 85] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2015] [Accepted: 04/29/2016] [Indexed: 11/16/2022]
Abstract
Background—
Transcatheter valve implantation inside failed bioprosthetic surgical valves (valve-in-valve [ViV]) may offer an advantage over reoperation. Supra-annular transcatheter valve position may be advantageous in achieving better hemodynamics after ViV. Our objective was to define targets for implantation that would improve hemodynamics after ViV.
Methods and Results—
Cases from the Valve-in-Valve International Data (VIVID) registry were analyzed using centralized core laboratory assessment blinded to clinical events. Multivariate analysis was performed to identify independent predictors of elevated postprocedural gradients (mean ≥20 mm Hg). Optimal implantation depths were defined by receiver operating characteristic curve. A total of 292 consecutive patients (age, 78.9±8.7 years; 60.3% male; 157 CoreValve Evolut and 135 Sapien XT) were evaluated. High implantation was associated with significantly lower rates of elevated gradients in comparison with low implantation (CoreValve Evolut, 15% versus 34.2%;
P
=0.03 and Sapien XT, 18.5% versus 43.5%;
P
=0.03, respectively). Optimal implantation depths were defined: CoreValve Evolut, 0 to 5 mm; Sapien XT, 0 to 2 mm (0–10% frame height); sensitivities, 91.3% and 88.5%, respectively. The strongest independent correlate for elevated gradients after ViV was device position (high: odds ratio, 0.22; confidence interval, 0.1–0.52;
P
=0.001), in addition to type of device used (CoreValve Evolut: odds ratio, 0.5; confidence interval, 0.28–0.88;
P
=0.02) and surgical valve mechanism of failure (stenosis/mixed baseline failure: odds ratio, 3.12; confidence interval, 1.51–6.45;
P
=0.002).
Conclusions—
High implantation inside failed bioprosthetic valves is a strong independent correlate of lower postprocedural gradients in both self- and balloon-expandable transcatheter valves. These clinical evaluations support specific implantation targets to optimize hemodynamics after ViV.
Collapse
Affiliation(s)
- Matheus Simonato
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - John Webb
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Ran Kornowski
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Alec Vahanian
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Christian Frerker
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Henrik Nissen
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Sabine Bleiziffer
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Alison Duncan
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Josep Rodés-Cabau
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Guilherme F. Attizzani
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Eric Horlick
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Azeem Latib
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Raffi Bekeredjian
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Marco Barbanti
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Thierry Lefevre
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Alfredo Cerillo
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - José María Hernández
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Giuseppe Bruschi
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Konstantinos Spargias
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Alessandro Iadanza
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Stephen Brecker
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - José Honório Palma
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Ariel Finkelstein
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Mohamed Abdel-Wahab
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Pedro Lemos
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Anna Sonia Petronio
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Didier Champagnac
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Jan-Malte Sinning
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Stefano Salizzoni
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Massimo Napodano
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Claudia Fiorina
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Antonio Marzocchi
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Martin Leon
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| | - Danny Dvir
- From the Centre for Heart Valve Innovation, Department of Cardiology, St. Paul’s Hospital, Vancouver, Canada (M.S., J.W., D.D.); Division of Cardiovascular Surgery, Escola Paulista de Medicina—UNIFESP, São Paulo, Brazil (M.S., J.H.P.); Interventional Cardiology Institute, Cardiology Department, Rabin Medical Center, Petah Tivka, Israel (R.K.); Cardiology Department, Hôpital Bichat-Claude Bernard, Paris, France (A.V.); Department of Cardiology, Asklepios Klinik, Hamburg, Germany (C. Frerker)
| |
Collapse
|
169
|
Chopra H, Arangalage D, Bouleti C, Zarka S, Fayard F, Chillon S, Laissy JP, Henry-Feugeas MC, Steg PG, Vahanian A, Ou P. Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. Int J Cardiol 2016; 212:63-9. [PMID: 27035605 DOI: 10.1016/j.ijcard.2016.03.004] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/22/2016] [Accepted: 03/12/2016] [Indexed: 12/13/2022]
Abstract
BACKGROUND Prognostic value of the infarct- and non-infarct like patterns and cardiac magnetic resonance (CMR) parameters on long-term outcome of patients after acute myocarditis is not well known. METHODS Between 2006 and 2015, 112 consecutive patients with CMR-based diagnosis of acute myocarditis were identified in our institution. Of them, 88 were available for clinical follow-up and represented our studied population. Patients were divided into infarct-like group (n=48) (association of acute chest pain, elevated Troponin levels and ST-elevation) and non-infarct-like group (n=40) with any other presentation. The composite primary endpoint of major cardiovascular events (MACE) included: all-cause mortality, cardiac mortality, recurrence of myocarditis, heart failure, and sustained ventricular tachycardia. RESULTS During follow-up, 21 patients (24%) experienced MACE and infarct-like patients were significantly more at risk for MACE than non-infarct-like patients (HR 2.4, 95% CI [1.01-5.80] p=0.04). Infarct-like patients exhibited in particular a higher risk of sustained ventricular tachycardia and recurrence of myocarditis (p=0.03). They had lower CMR-derived left (p=0.03) and right (p=0.001) ventricular ejection fractions, and exhibited larger areas of late gadolinium enhancement (LGE) (p=0.001). In multivariate analysis, both initial NYHA functional class >II and LGE mass were independent predictors for long-term MACE occurrence (HR 5.8 and 1.07 per gram respectively, p=0.007). Moreover, a threshold of LGE mass >17g provided a high discrimination for MACE occurrence (AUC of 0.81). CONCLUSIONS The infarct-like pattern of acute myocarditis is associated with MACE occurrence. Initial NYHA functional class >II and LGE are independent predictive factors of MACE during long-term follow-up after acute myocarditis.
Collapse
Affiliation(s)
- Houzefa Chopra
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Dimitri Arangalage
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; Faculté de Médecine, Paris-Diderot University, Paris, France; DHU Fire, Paris-Diderot University, France
| | - Claire Bouleti
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; Faculté de Médecine, Paris-Diderot University, Paris, France; DHU Fire, Paris-Diderot University, France
| | - Samuel Zarka
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Florence Fayard
- Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, 94805, France; CESP Centre for Research in Epidemiology and Population Health, INSERM U1018 (Team 2, Methodology and clinical epidemiology in molecular oncology), Université Paris-Sud, Villejuif 94805, France
| | - Sylvie Chillon
- Department of Radiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
| | - Jean-Pierre Laissy
- Faculté de Médecine, Paris-Diderot University, Paris, France; DHU Fire, Paris-Diderot University, France; Department of Radiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; INSERM U1148 Bichat Hospital, Paris, France
| | | | - Philippe-Gabriel Steg
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; Faculté de Médecine, Paris-Diderot University, Paris, France; DHU Fire, Paris-Diderot University, France; INSERM U1148 Bichat Hospital, Paris, France
| | - Alec Vahanian
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; Faculté de Médecine, Paris-Diderot University, Paris, France; DHU Fire, Paris-Diderot University, France; INSERM U1148 Bichat Hospital, Paris, France
| | - Phalla Ou
- Faculté de Médecine, Paris-Diderot University, Paris, France; DHU Fire, Paris-Diderot University, France; Department of Radiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France; INSERM U1148 Bichat Hospital, Paris, France.
| |
Collapse
|
170
|
Murray S, Antz M, Heidbuchel H, Carrera C, Lazure P, Vahanian A, Hindricks G. 17-01: Challenges in selecting rate vs. rhythm control in Atrial Fibrillation. Europace 2016. [DOI: 10.1093/europace/18.suppl_1.i161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
171
|
Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence MS, Redwood S, Kahlert P, Rodes-Cabau J, Leipsic J, Webb J. Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial. EUROINTERVENTION 2016; 12:e235-43. [DOI: 10.4244/eijv12i2a37] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
172
|
Guerrero M, Urena M, Pursnani A, Wang DD, Vahanian A, O'Neill W, Feldman T, Himbert D. Balloon expandable transcatheter heart valves for native mitral valve disease with severe mitral annular calcification. J Cardiovasc Surg (Torino) 2016; 57:401-409. [PMID: 27094423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Patients with mitral annular calcification (MAC) have high surgical risk for mitral valve replacement due to associated comorbidities and technical challenges related to calcium burden, precluding surgery in many patients. Transcatheter mitral valve replacement (TMVR) with the compassionate use of balloon expandable aortic transcatheter heart valves has been used in this clinical scenario. The purpose of this review was to summarize the early experience including successes and failures reported. TMVR might evolve into an acceptable alternative for selected patients with severe MAC who are not candidates for conventional mitral valve surgery. However, this field is at a very early stage and the progress will be significantly slower than the development of transcatheter aortic valve replacement due to the complexity of the mitral valve anatomy and its pathology. Optimizing patient selection process by using multimodality imaging tools to accurately measure the mitral valve annulus and evaluate the risk of left ventricular outflow tract obstruction is essential to minimize complications. Strategies for treating and preventing left ventricular outflow tract obstruction are being tested. Similarly, carefully selecting candidates avoiding patients at the end of their disease process, might improve the overall outcomes.
Collapse
Affiliation(s)
- Mayra Guerrero
- Division of Cardiology, Evanston Hospital, North Shore University Health System, Evanston, IL, USA -
| | | | | | | | | | | | | | | |
Collapse
|
173
|
Brochet É, Ducrocq G, Extramiana F, Feldman L, Himbert D, Iung B, Jondeau G, Juliard JM, Steg G, Vahanian A. [What's new in cardiology]. Rev Prat 2016; 66:633-640. [PMID: 27538320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
|
174
|
Tarantini G, Mojoli M, Windecker S, Wendler O, Lefèvre T, Saia F, Walther T, Rubino P, Bartorelli AL, Napodano M, D’Onofrio A, Gerosa G, Iliceto S, Vahanian A. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv 2016; 9:937-46. [DOI: 10.1016/j.jcin.2016.01.037] [Citation(s) in RCA: 119] [Impact Index Per Article: 14.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/15/2015] [Revised: 01/14/2016] [Accepted: 01/28/2016] [Indexed: 11/26/2022]
|
175
|
Abdelghani M, Soliman OI, Schultz C, Vahanian A, Serruys PW. Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal. Eur Heart J 2016; 37:2627-44. [DOI: 10.1093/eurheartj/ehw115] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/07/2015] [Accepted: 03/01/2016] [Indexed: 12/18/2022] Open
|
176
|
Zarka S, Bouleti C, Arangalage D, Chopra H, Baudry G, Steg PG, Vahanian A, Laissy JP, Ou P. 0083 : Hyperhemia on the first-pass MRI perfusion for the diagnosis of acute myocarditis. Archives of Cardiovascular Diseases Supplements 2016. [DOI: 10.1016/s1878-6480(16)30497-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
177
|
Chopra H, Arangalage D, Bouleti C, Zarka S, Fayard F, Chillon S, Steg PG, Vahanian A, Ou P, Laissy JP. 0261 : Prognostic value of the “infarct-like” pattern and cardiovascular magnetic resonance parameters for long-term outcome after an acute myocarditis. Archives of Cardiovascular Diseases Supplements 2016. [DOI: 10.1016/s1878-6480(16)30494-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
178
|
Rodés-Cabau J, Hahn RT, Latib A, Laule M, Lauten A, Maisano F, Schofer J, Campelo-Parada F, Puri R, Vahanian A. Transcatheter Therapies for Treating Tricuspid Regurgitation. J Am Coll Cardiol 2016; 67:1829-1845. [DOI: 10.1016/j.jacc.2016.01.063] [Citation(s) in RCA: 137] [Impact Index Per Article: 17.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/19/2015] [Revised: 12/28/2015] [Accepted: 01/07/2016] [Indexed: 10/22/2022]
|
179
|
Alos B, Bouleti C, Himbert D, Iung B, Urena M, Dilly MP, Brochet E, Ou P, Nataf P, Vahanian A. 0007 : Seven-year outcome after TAVI. Archives of Cardiovascular Diseases Supplements 2016. [DOI: 10.1016/s1878-6480(16)30513-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
180
|
Baudry G, Bouleti C, Lung B, Ducrocq G, Choquet C, Zarka S, Laissy JP, Steg PG, Vahanian A, Ou P. 0320 : Cardiac spectral CT scan to diagnose acute myocarditis: a new imaging technique. Archives of Cardiovascular Diseases Supplements 2016. [DOI: 10.1016/s1878-6480(16)30493-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
181
|
Bouleti C, Himbert D, Brochet E, Ou P, Iung B, Urena M, Ghodbane W, Fassa AA, Nataf P, Vahanian A. TRANSFEMORAL TRICUSPID VALVE-IN-VALVE AND VALVE-IN-RING IMPLANTATION USING THE EDWARDS SAPIEN XT VALVE: ONE-YEAR FOLLOW-UP. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)30285-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
182
|
Chauvet M, Bouleti C, Himbert D, Iung B, Brochet E, Alos B, Ghodbane W, Provenchère S, Nataf P, Vahanian A. 0069 : Early and late outcome after transcatheter aortic valve implantation or surgical aortic valve replacement for high risk patients with aortic stenosis: a monocentric experience. Archives of Cardiovascular Diseases Supplements 2016. [DOI: 10.1016/s1878-6480(16)30509-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
183
|
Kuck KH, Maisano F, Alfieri O, Colombo A, Baldus S, Vahanian A, Nickenig G. UP TO ONE-YEAR FOLLOW-UP RESULTS FROM A MULTICENTER TRIAL OF A TRANSFEMORAL SYSTEM FOR MITRAL VALVE RECONSTRUCTION. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)30032-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
184
|
Arsalan M, Agricola E, Alfieri O, Baldus S, Colombo A, Filardo G, Hammerstingl C, Huntgeburth M, Kreidel F, Kuck KH, Canna GL, Messika-Zeitoun D, Maisano F, Nickenig G, Pollock BD, Roberts BJ, Vahanian A, Grayburn P. EFFECT OF TRANSCATHETER MITRAL REPAIR WITH THE CARDIOBAND DEVICE ON 3-DIMENSIONAL GEOMETRY OF THE MITRAL ANNULUS. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)30337-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
185
|
Yang TH, Webb JG, Blanke P, Dvir D, Hansson NC, Nørgaard BL, Thompson CR, Thomas M, Wendler O, Vahanian A, Himbert D, Kodali SK, Hahn RT, Thourani VH, Schymik G, Precious B, Berger A, Wood DA, Pibarot P, Rodés-Cabau J, Jaber WA, Leon MB, Walther T, Leipsic J. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. JACC Cardiovasc Interv 2016; 8:462-471. [PMID: 25790764 DOI: 10.1016/j.jcin.2014.10.014] [Citation(s) in RCA: 110] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2014] [Revised: 09/10/2014] [Accepted: 10/08/2014] [Indexed: 10/23/2022]
Abstract
OBJECTIVES This study sought to compare the influence of the extent of multidetector computed tomography (MDCT) area oversizing on the incidence of paravalvular aortic regurgitation (PAR) between the Sapien 3 and the Sapien XT transcatheter heart valve (THV) to define a new MDCT sizing guideline suitable for the Sapien 3 platform. BACKGROUND The inverse relationship of PAR occurrence and oversizing has been demonstrated for the Sapien XT but the incidence of PAR with comparable oversizing with the Sapien 3 is not known. METHODS Sixty-one prospectively enrolled patients who underwent transcatheter aortic valve replacement with the Sapien 3 THV were compared with 92 patients who underwent transcatheter aortic valve replacement with the Sapien XT THV. Patients were categorized depending on the degree of MDCT area oversizing percentage: undersizing (below 0%), 0% to 5%, 5% to 10%, and above 10%. The primary endpoint was mild or greater PAR on transthoracic echocardiography. RESULTS Mild or greater PAR was present in 19.7% of patients (12 of 61) in the Sapien 3 group and in 54.3% of patients (50 of 92) in the Sapien XT group (p < 0.01). The Sapien 3 group, compared with the Sapien XT group, consistently demonstrated significantly lower rates of mild or greater PAR except for oversizing >10% (p for interaction = 0.54). Moderate or severe PAR rates were also lower in the Sapien 3 group than in the Sapien XT group (3.3% vs. 13.0%, p = 0.04). In the Sapien 3 group, a MDCT area oversizing percentage value of ≤4.17% was identified as the optimal cutoff value to discriminate patients with or without mild or greater PAR. CONCLUSIONS Our retrospective analysis suggests that the Sapien 3 THV displays significantly lower rates of PAR than does the Sapien XT THV. A lesser degree of MDCT area oversizing may be employed for this new balloon-expandable THV.
Collapse
Affiliation(s)
- Tae-Hyun Yang
- Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada; Inje University Busan Paik Hospital, Busan, South Korea
| | - John G Webb
- Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - Philipp Blanke
- Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - Danny Dvir
- Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - Nicolaj C Hansson
- Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
| | - Bjarne L Nørgaard
- Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
| | - Christopher R Thompson
- Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - Martyn Thomas
- Department of Cardiology, St. Thomas's Hospital, London, United Kingdom
| | - Olaf Wendler
- Department of Surgery, King's College Hospital/King's Health Partners, London, United Kingdom
| | - Alec Vahanian
- Department of Cardiology, Bichat Hospital, Paris, France
| | | | - Susheel K Kodali
- Department of Cardiology, Columbia University Medical Center/New York Presbyterian Hospital, New York, New York
| | - Rebecca T Hahn
- Department of Cardiology, Columbia University Medical Center/New York Presbyterian Hospital, New York, New York
| | - Vinod H Thourani
- Department of Surgery, Emory University School of Medicine, Atlanta, Georgia
| | - Gerhard Schymik
- Department of Cardiology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany
| | - Bruce Precious
- Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - Adam Berger
- Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - David A Wood
- Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - Philippe Pibarot
- Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada
| | - Josep Rodés-Cabau
- Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada
| | | | - Martin B Leon
- Department of Cardiology, Columbia University Medical Center/New York Presbyterian Hospital, New York, New York
| | - Thomas Walther
- Department of Surgery, Kerckhoff Heart Center, Bad Nauheim, Germany
| | - Jonathon Leipsic
- Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
| |
Collapse
|
186
|
Abstract
The field of mitral valve disease diagnosis and management is rapidly changing. New understanding of disease pathology and progression, with improvements in and increased use of sophisticated imaging modalities, have led to early diagnosis and complex treatment. In primary mitral regurgitation, surgical repair is the standard of care. Treatment of asymptomatic patients with severe mitral regurgitation in valve reference centres, in which successful repair is more than 95% and surgical mortality is less than 1%, should be the expectation for the next 5 years. Transcatheter mitral valve repair with a MitraClip device is also producing good outcomes in patients with primary mitral regurgitation who are at high surgical risk. Findings from clinical trials of MitraClip versus surgery in patients of intermediate surgical risk are expected to be initiated in the next few years. In patients with secondary mitral regurgitation, mainly a disease of the left ventricle, the vision for the next 5 years is not nearly as clear. Outcomes from ongoing clinical trials will greatly inform this field. Use of transcatheter techniques, both repair and replacement, is expected to substantially expand. Mitral annular calcification is an increasing problem in elderly people, causing both mitral stenosis and regurgitation which are difficult to treat. There is anecdotal experience with use of transcatheter valves by either a catheter-based approach or as a hybrid technique with open surgery, which is being studied in early feasibility trials.
Collapse
|
187
|
Vahanian A. CardioPulse: Valvular interventions from the Europeanperspective. Eur Heart J 2016; 37:796-7. [PMID: 26951576 DOI: 10.1093/eurheartj/ehw009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
188
|
Bouleti C, Amsallem M, Touati A, Himbert D, Iung B, Alos B, Brochet E, Urena M, Ghodbane W, Ou P, Dilly MP, Nataf P, Vahanian A. Early and late outcomes after trans-catheter aortic valve implantation in patients with previous chest radiation. Heart 2016; 102:1044-51. [DOI: 10.1136/heartjnl-2015-309101] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/01/2015] [Accepted: 02/03/2016] [Indexed: 11/04/2022] Open
|
189
|
Chin CWL, Messika-Zeitoun D, Shah ASV, Lefevre G, Bailleul S, Yeung ENW, Koo M, Mirsadraee S, Mathieu T, Semple SI, Mills NL, Vahanian A, Newby DE, Dweck MR. A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis. Eur Heart J 2016; 37:713-23. [PMID: 26491110 PMCID: PMC4761400 DOI: 10.1093/eurheartj/ehv525] [Citation(s) in RCA: 79] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/29/2015] [Revised: 08/24/2015] [Accepted: 09/17/2015] [Indexed: 11/20/2022] Open
Abstract
AIMS Midwall myocardial fibrosis on cardiovascular magnetic resonance (CMR) is a marker of early ventricular decompensation and adverse outcomes in aortic stenosis (AS). We aimed to develop and validate a novel clinical score using variables associated with midwall fibrosis. METHODS AND RESULTS One hundred forty-seven patients (peak aortic velocity (Vmax) 3.9 [3.2,4.4] m/s) underwent CMR to determine midwall fibrosis (CMR cohort). Routine clinical variables that demonstrated significant association with midwall fibrosis were included in a multivariate logistic score. We validated the prognostic value of the score in two separate outcome cohorts of asymptomatic patients (internal: n = 127, follow-up 10.3 [5.7,11.2] years; external: n = 289, follow-up 2.6 [1.6,4.5] years). Primary outcome was a composite of AS-related events (cardiovascular death, heart failure, and new angina, dyspnoea, or syncope). The final score consisted of age, sex, Vmax, high-sensitivity troponin I concentration, and electrocardiographic strain pattern [c-statistic 0.85 (95% confidence interval 0.78-0.91), P < 0.001; Hosmer-Lemeshow χ(2) = 7.33, P = 0.50]. Patients in the outcome cohorts were classified according to the sensitivity and specificity of this score (both at 98%): low risk (probability score <7%), intermediate risk (7-57%), and high risk (>57%). In the internal outcome cohort, AS-related event rates were >10-fold higher in high-risk patients compared with those at low risk (23.9 vs. 2.1 events/100 patient-years, respectively; log rank P < 0.001). Similar findings were observed in the external outcome cohort (31.6 vs. 4.6 events/100 patient-years, respectively; log rank P < 0.001). CONCLUSION We propose a clinical score that predicts adverse outcomes in asymptomatic AS patients and potentially identifies high-risk patients who may benefit from early valve replacement.
Collapse
Affiliation(s)
- Calvin W L Chin
- British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK National Heart Center Singapore, Singapore, Singapore
| | | | - Anoop S V Shah
- British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK
| | | | - Sophie Bailleul
- Biochemistry Department, AP-HP, Tenon Hospital, Paris, France
| | - Emily N W Yeung
- British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK
| | - Maria Koo
- British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK
| | - Saeed Mirsadraee
- British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK
| | - Tiffany Mathieu
- Cardiology Department, AP-HP, Bichat Hospital, Paris, France
| | - Scott I Semple
- British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK
| | - Nicholas L Mills
- British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK
| | - Alec Vahanian
- Cardiology Department, AP-HP, Bichat Hospital, Paris, France
| | - David E Newby
- British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK
| | - Marc R Dweck
- British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK
| |
Collapse
|
190
|
Affiliation(s)
- Bernard Iung
- Cardiology Department, Bichat Hospital, AP-HP, Paris Diderot University, DHU Fire, Paris, France
| | - Alec Vahanian
- Cardiology Department, Bichat Hospital, AP-HP, Paris Diderot University, DHU Fire, Paris, France
| |
Collapse
|
191
|
Arangalage D, Nguyen V, Robert T, Melissopoulou M, Mathieu T, Estellat C, Codogno I, Huart V, Duval X, Cimadevilla C, Vahanian A, Dehoux M, Messika-Zeitoun D. Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis. Heart 2016; 102:862-8. [DOI: 10.1136/heartjnl-2015-308873] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/20/2015] [Accepted: 01/21/2016] [Indexed: 11/04/2022] Open
|
192
|
Latib A, Naganuma T, Abdel-Wahab M, Danenberg H, Cota L, Barbanti M, Baumgartner H, Finkelstein A, Legrand V, de Lezo JS, Kefer J, Messika-Zeitoun D, Richardt G, Stabile E, Kaleschke G, Vahanian A, Laborde JC, Leon MB, Webb JG, Panoulas VF, Maisano F, Alfieri O, Colombo A. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv 2016. [PMID: 25873727 DOI: 10.1161/circinter ventions.114.001779] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
BACKGROUND Valve thrombosis has yet to be fully evaluated after transcatheter aortic valve implantation. This study aimed to report the prevalence, timing, and treatment of transcatheter heart valve (THV) thrombosis. METHODS AND RESULTS THV thrombosis was defined as follows (1) THV dysfunction secondary to thrombosis diagnosed based on response to anticoagulation therapy, imaging modality or histopathology findings, or (2) mobile mass detected on THV suspicious of thrombus, irrespective of dysfunction and in absence of infection. Between January 2008 and September 2013, 26 (0.61%) THV thromboses were reported out of 4266 patients undergoing transcatheter aortic valve implantation in 12 centers. Of the 26 cases detected, 20 were detected in the Edwards Sapien/Sapien XT cohort and 6 in the Medtronic CoreValve cohort. In patients diagnosed with THV thrombosis, the median time to THV thrombosis post-transcatheter aortic valve implantation was 181 days (interquartile range, 45-313). The most common clinical presentation was exertional dyspnea (n=17; 65%), whereas 8 (31%) patients had no worsening symptoms. Echocardiographic findings included a markedly elevated mean aortic valve pressure gradient (40.5±14.0 mm Hg), presence of thickened leaflets or thrombotic apposition of leaflets in 20 (77%) and a thrombotic mass on the leaflets in the remaining 6 (23%) patients. In 23 (88%) patients, anticoagulation resulted in a significant decrease of the aortic valve pressure gradient within 2 months. CONCLUSIONS THV thrombosis is a rare phenomenon that was detected within the first 2 years after transcatheter aortic valve implantation and usually presented with dyspnea and increased gradients. Anticoagulation seems to have been effective and should be considered even in patients without visible thrombus on echocardiography.
Collapse
Affiliation(s)
- Azeem Latib
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.).
| | - Toru Naganuma
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Mohamed Abdel-Wahab
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Haim Danenberg
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Linda Cota
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Marco Barbanti
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Helmut Baumgartner
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Ariel Finkelstein
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Victor Legrand
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - José Suárez de Lezo
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Joelle Kefer
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - David Messika-Zeitoun
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Gert Richardt
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Eugenio Stabile
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Gerrit Kaleschke
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Alec Vahanian
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Jean-Claude Laborde
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Martin B Leon
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - John G Webb
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Vasileios F Panoulas
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Francesco Maisano
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Ottavio Alfieri
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| | - Antonio Colombo
- From the Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy (A.L., T.N., V.F.P., A.C.); Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy (A.L., T.N., V.F.P., A.C.); Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany (M.A.-W., G.R.); Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (H.D.); Division of Cardiology, Cardiac Catheterization Laboratories, Clinica Montevergine, Mercogliano, Italy (L.C., E.S.); Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (M.B., J.G.W.); Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany (H.B., G.K.); Interventional Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel (A.F.); Department of Cardiology, CHU de Liege, Liege, Belgium (V.L.); Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain (J.S.d.L.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Universite´ Catholique de Louvain, Brussels, Belgium (J.K.); Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France (D.M.-Z., A.V.); Deaprtment of Cardiology, St. George's Hospital, London, United Kingdom (J.-C.L.); Columbia University Medical Center and Cardiovascular Research Foundation, New York (M.B.L.); and Department of Cardiothoracic Surgery, San Raffaele Scientific Institute, Milan, Italy (F.M., O.A.)
| |
Collapse
|
193
|
|
194
|
Vahanian A, Kuck KH, Alfieri O, Colombo A, Baldus S, Nickenig G, Maisano F. CRT-400.16 Transfemoral System for Mitral Valve Reconstruction - A Multicentre Experience. JACC Cardiovasc Interv 2016. [DOI: 10.1016/j.jcin.2015.12.239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
195
|
Salaun E, Pankert M, Habib G, Bonnet JL, Vahanian A, Himbert D, Brochet E, Nataf P, D’Ancona G, Kische S, Öner A, Ince H. How should I treat refractory cardiogenic shock in a patient with chronic biventricular heart failure and mitral regurgitation with difficult valve characteristics? EUROINTERVENTION 2016; 11:1201-6. [DOI: 10.4244/eijv11i10a238] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
196
|
Affiliation(s)
- Bernard Iung
- Cardiology Department, Bichat Hospital, AP-HP, Paris Diderot University, DHU Fire, 46 rue Henri Huchard, Paris 75018, France
| | | | - Alec Vahanian
- Cardiology Department, Bichat Hospital, AP-HP, Paris Diderot University, DHU Fire, 46 rue Henri Huchard, Paris 75018, France
| |
Collapse
|
197
|
Arangalage D, Nguyen V, Robert T, Melissopoulou M, Mathieu T, Estellat C, Codogno I, Huart V, Duval X, Cimadevilla C, Iung B, Dehoux M, Vahanian A, Messika-Zeitoun D. 0574: Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis - the COFRASA-GENERAC study. Archives of Cardiovascular Diseases Supplements 2016. [DOI: 10.1016/s1878-6480(16)30175-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
198
|
Affiliation(s)
- Alec Vahanian
- Cardiology Department, Bichat Hospital, AP-HP; University Paris Diderot, Paris, France.
| | - Jean Michel Juliard
- Cardiology Department, Bichat Hospital, AP-HP; University Paris Diderot, Paris, France
| |
Collapse
|
199
|
Martins Fernandes S, Badano L, Garcia Campos A, Erdei T, Mehdipoor G, Hanboly N, Michalski BW, Vriz O, Mo VY, Le TT, Ribeiro JM, Ternacle J, Yurdakul SELEN, Shetye A, Stoebe S, Lisowska A, Chinali M, Orabona M, Contaldi C, De La Chica JA, Codolosa JN, Trzcinski P, Prado Diaz S, Morales Portano JD, Ha SJ, Valente F, Joseph G, Valente F, Scali MC, Cordeiro F, Duchateau N, Fabris E, Costantino MF, Cho IJ, Goublaire C, Lam W, Galli E, Kim KH, Mariani M, Malev E, Zuercher F, Tang Z, Cimino S, Mahia P, De La Chica JA, Petrovic J, Ciobotaru V, Remsey- Semmelweiss E, Kogoj P, Guerreiro S, Saxena A, Mozenska O, Pontone G, Macaya Ten F, Caballero L, Avegliano G, Halmai L, Reis L, Trifunovic D, Gospodinova M, Makavos G, D'ascenzi F, Dantas Tavares De Melo M, Bonapace S, Kulkarni A, Cameli M, Ingvarsson A, Driessen MMP, Tufekcioglu O, Radulescu D, Barac A, Cioffi G, Almeida Morais L, Ledakowicz-Polak A, Portugal G, Naksuk N, Parato VM, Kovalova S, Cherubini A, Corrado G, Malev E, Wierzbowska-Drabik K, Lesevic H, Laredj N, Pieles GE, Generati G, Van Zalen JJ, Aquila I, Cheng HL, Lanzoni L, Asmarats Serra L, Kadrabulatova S, Ranjbar S, Szczesniak-Stanczyk D, Sharka I, Di Salvo G, Ben Kahla S, Li L, Hadeed HA, Habeeb HA, Toscano A, Granata F, Djikic D, Wdowiak-Okrojek K, Girgis HYA, Sharma A, Soro C, Gallego Page JC, Corneli M, Teixeira R, Roussin I, Lynch M, Muraru D, Romeo G, Ermacora D, Marotta C, Aruta P, Cucchini U, Iliceto S, Martin-Fernandez M, De La Hera Galarza JM, Corros-Vicente C, Colunga Blanco S, Velasco-Alonso E, Leon-Aguero V, Rodriguez-Suarez ML, Moris De La Tassa C, Edwards J, Braim D, Price C, Fraser AG, Salmani F, Arjmand Shabestari A, Szymczyk E, Kupczynska K, Peczek L, Nawrot B, Lipiec P, Kasprzak JD, Driussi C, Ferrara F, Brosolo G, Antonini-Canterin F, Magne J, Aboyans V, Bossone E, Bellucci BM, Fisher JM, Balekian AA, Idapalapati S, Huang F, Wong JI, Tan RS, Teixeira R, Madeira M, Almeida I, Reis L, Siserman A, Dinis P, Dias L, Ramos AP, Goncalves L, Wan FW, Sawaki DS, Dubois-Rande JLDR, Adnot SA, Czibik GC, Derumeaux GD, Ercan G, Tekkesin ILKER, Sahin ST, Cengiz B, Celik G, Demircan S, Aytekin SAIDE, Razvi NA, Nazir SA, Price N, Khan JN, Kanagala P, Singh A, Squire I, Mccann GP, Langel M, Pfeiffer D, Hagendorff A, Ptaszynska-Kopczynska K, Marcinkiewicz-Siemion M, Knapp M, Witkowski M, Musial WJ, Kaminski K, Natali B, D' Anna C, Leonardi B, Secinaro A, Pongiglione G, Rinelli G, Renard S, Michel N, Mancini J, Haentjens J, Sitbon O, Habib G, Imbriaco M, Alcidi G, Santoro C, Buonauro A, Lo Iudice F, Lembo M, Cuocolo A, Trimarco B, Galderisi M, Mora Robles J, Roldan Jimenez MA, Mancisidor MA, De Mora MA, Alnabelsi T, Goykhman I, Koshkelashvili N, Romero-Corral A, Pressman GS, Michalski BW, Kupczynska K, Miskowiec D, Lipiec P, Kasprzak JD, Montoro Lopez N, Refoyo Salicio E, Valbuena Lopez SC, Gonzalez O, Alvarez C, Moreno Yanguela M, Bartha Rasero JL, De La Calle M, Guzman Martinez G, Suarez-Cuenca JA, Merino JA, Gomez Alvarez EB, Delgado LG, Woo YM, Bang WD, Sohn GH, Cheong SS, Yoo SY, Rodriguez Palomares JF, Gutierrez L, Maldonado G, Pineda V, Galian L, Teixido G, Gonzalez Allujas MT, Evangelista A, Garcia Dorado D, Zaremba T, Ekeloef S, Heiberg E, Engblom H, Jensen SE, Sogaard P, Rodriguez Palomares JF, Gutierrez L, Garcia G, Pineda V, Galian L, Teixido G, Gonzalez Allujas MT, Evangelista A, Garcia Dorado D, Dini FL, Galli F, Lattanzi F, Picano E, Marzilli M, Leao S, Moz M, Magalhaes P, Trigo J, Mateus PS, Ferreira A, Moreira JI, De Craene M, Legallois D, Labombarda F, Pellissier A, Sermesant M, Saloux E, Merlo M, Moretti M, Barbati G, Stolfo D, Gigli M, Pinamonti B, Sinagra G, Dores E, Matera A, Innelli P, Innelli P, Lopizzo A, Violini R, Fiorilli R, Cappabianca G, Picano E, Tarsia G, Seo J, Chang HJ, Heo R, Kim IC, Shim CY, Hong GR, Chung N, Melissopoulou MM, Nguyen V, Brochet E, Cimadevilla C, Codogno I, Vahanian A, Messika-Zeitoun D, Pontana F, Vassiliou V, Prasad S, Leclercq C, Samset E, Donal E, Lim DS, Bianchi G, Rossi F, Gianetti J, Marchi F, Cerone E, Nardelli A, Terrazzi M, Solinas M, Maffei S, Pshepiy A, Vasina L, Timofeev E, Reeva S, Zemtsovsky E, Brugger N, Jahren S, De Marchi SF, Seiler C, Jin CN, Tang H, Fan K, Kam K, Yan BP, Yu CM, Lee PW, Reali M, Silvetti E, Salatino T, Mancone M, Pennacchi M, Giordano A, Sardella G, Agati L, Tirado G, Nogales-Romo MT, Marcos-Alberca P, De Agustin A, Almeria C, Rodrigo JL, Garcia Fernandez MA, Macaya C, Perez De Isla L, Mancisidor M, Lara Garcia C, Vivancos R, De Mora M, Petrovic M, Vujisic-Tesic B, Trifunovic D, Boricic-Kostic M, Petrovic I, Draganic G, Petrovic O, Tomic-Dragovic M, Furlan T, Ambrozic J, Mohorko Pleskovic PN, Bunc M, Ribeiras R, Abecasis J, Andrade MJ, Mendes M, Ramakrishnan S, Gupta SK, Juneja R, Kothari SS, Zaleska M, Segiet A, Chwesiuk S, Kroc A, Kosior DA, Andreini D, Solbiati A, Guglielmo M, Mushtaq S, Baggiano A, Beltrama V, Rota C, Guaricci AI, Pepi M, Pons Llinares J, Asmarats Serra L, Pericas Ramis P, Caldes Llull O, Grau Sepulveda A, Frontera G, Vaquer Segui A, Noris M, Bethencourt Gonzalez A, Climent Paya V, Martinez Moreno M, Saura D, Oliva MJ, Sanchez Quinones J, Garcia Honrubia A, Valdes M, De La Morena G, Terricabras M, Costabel JP, Ronderos R, Evangelista A, Venturini C, Galve E, Nemes A, Neubauer S, Rahman Haley S, Banner N, Teixeira R, Caetano F, Almeida I, Trigo J, Botelho A, Silva J, Nascimento J, Goncalves L, Tesic M, Jovanovic I, Petrovic O, Boricic-Kostic M, Dragovic M, Petrovic M, Stepanovic J, Banovic M, Vujisic-Tesic B, Guergelcheva V, Chamova T, Sarafov S, Tournev I, Denchev S, Ikonomidis I, Psarogiannakopoulos P, Tsirigotis P, Paraskevaidis I, Lekakis J, Pelliccia A, Natali BM, Cameli M, Focardi M, Bonifazi M, Mondillo S, Lima C, Assed L, Kalil Filho R, Mady C, Bochi EA, Salemi VMC, Targher G, Valbusa F, Rossi A, Lanzoni L, Lipari P, Zenari L, Molon G, Canali G, Barbieri E, Li L, Craft M, Nanda M, Lorenzo JM, Kutty S, Bombardini T, Sparla S, Di Tommaso C, Losito M, Incampo E, Maccherini M, Mondillo S, Werther Evaldsson A, Radegran G, Stagmo M, Waktare J, Roijer A, Meurling CJ, Hui W, Meijboom FJ, Bijnens B, Dragulescu A, Mertens L, Friedberg MK, Sensoy B, Suleymanoglu M, Akin Y, Sahan E, Sasmaz H, Pasca L, Buzdugan E, Chis B, Stoicescu L, Lynce FC, Smith KL, Mete M, Isaacs C, Viapiana O, Di Nora C, Ognibeni F, Fracassi E, Giollo A, Mazzone C, Faganello G, Di Lenarda A, Rossini M, Galrinho A, Branco L, Timoteo AT, Rodrigues I, Daniel P, Rosa S, Ferreira L, Ferreira R, Polak L, Krauza G, Stokfisz K, Zielinska M, Branco LM, Galrinho A, Mota Carmo M, Teresa Timoteo A, Aguiar Rosa S, Abreu J, Pinto Teixeira P, Viveiros Monteiro A, Cruz Ferreira R, Peeraphatdit T, Chaiteerakij R, Klarich KW, Masia S, Necas J, Nistri S, Negri F, Barbati G, Cioffi G, Russo G, Mazzone C, Faganello G, Pandullo C, Di Lenarda A, Durante A, Rovelli E, Genchi V, Trabattoni L, Zerboni SC, Cattaneo L, Butti E, Ferrari G, Luneva E, Mitrofanova L, Uspensky V, Zemtsovsky E, Kasprzak JD, Rosner S, Karl M, Ott I, Sonne C, Ali Lahmar HM, Hammou L, Forsey J, Gowing L, Miller F, Ramanujam P, Stuart AG, Williams CA, Bandera F, Pellegrino M, Carbone F, Labate V, Alfonzetti E, Guazzi M, Patel NR, Raju P, Beale L, Brickley G, Lloyd GW, Fernandez-Golfin C, Gonzalez A, Rincon LM, Hinojar R, Garcia A, Megias A, Jimenez-Nacher JJ, Moya JL, Zamorano JL, Molon G, Canali G, Bonapace S, Chiampan A, Albrigi L, Barbieri E, Noris Mora M, Rodriguez Fernandez A, Exposito Pineda C, Grande C, Gonzalez Colino R, Macaya Ten F, Fernandez Vazquez X, Fortuny Frau E, Bethencourt Gonzalez A, Karvandi M, Blaszczyk R, Zarczuk R, Brzozowski W, Janowski M, Wysokinski A, Stanczyk B, Myftiu S, Teferici D, Quka A, Dado E, Djamandi J, Kresto L, Duka A, Kristo A, Balla I, Issa Z, Moiduddin N, Siblini G, Bulbul Z, Abid L, Abid D, Kammoun S, Rush E, Craft M, Goodwin J, Kreikemeier R, Cantinotti M, Kutty S, Zolaly MA, Khoshhal SQ, El-Harbi K, Tarawah A, Al-Hawsawi Z, Al-Mozainy I, Bakhoum SWG, Nabil MN, Elebrashy IN, Chinali M, Albanese S, Carotti A, Iacobelli R, Esposito C, Secinaro A, Moscogiuri G, Pasquini L, Malvezzi Caracciolo M, Bianchi RM, Caso P, Arenga F, Riegler L, Scarafile R, D'andrea A, Russo MG, Calabro' P, Simic DS, Peric VP, Mujovic NM, Marinkovic MM, Jankovic NJ, Shim A, Wejner-Mik P, Kasprzak JD, Lipiec P, Jain N, Kharwar R, Saran RK, Narain VS, Dwivedi SK, Sethi R, Chandra S, Pradhan A, Safal S, Marchetti MF, Cacace C, Congia M, Nissardi V, Ruscazio M, Meloni L, Montisci R, Gallego Sanchez G, Calero S, Portero JJ, Tercero A, Garcia JC, Barambio M, Martinez Lazaro R, Meretta AH, Perea GO, Belcastro F, Aguirre E, De Luca I, Henquin R, Masoli O. Poster session 2THE IMAGING EXAMINATIONP536Appropriate use criteria of transthoracic echocardiography and its clinical impact: a continuous challengeP537Implementation of proprietary plug-ins in the DICOM-based computerized echo reporting system fuels the use of 3D echo and deformation imaging in the clinical routine of a multivendor laboratoryP538Exercise stress echocardiography appropriate use criteria: real-life cases classification ease and agreement among cardiologistsANATOMY AND PHYSIOLOGY OF THE HEART AND GREAT VESSELSP539Functional capacity in older people with normal ejection fraction correlates with left ventricular functional reserve and carotid-femoral pulse wave velocity but not with E/e and augmentation indexP540Survey of competency of practitioners for diagnosis of acute cardiopulmonary diseases manifest on chest x-rayASSESSMENT OF DIAMETERS, VOLUMES AND MASSP541Left atrium remodeling in dialysis patients with normal ejection fractionP542The prediction of postinfarction left ventricular remodeling and the role of of leptin and MCP-1 in regard to the presence of metabolic syndromeP543Ascending aorta and common carotid artery: diameters and stiffness in a group of 584 healthy subjectsAssessments of haemodynamicsP544Alternate echo parameters in patients without estimable RVSPAssessment of systolic functionP545Reduced contractile performance in heart failure with preserved ejection fraction: determination using novel preload-adjusted maximal left ventricular ejection forceP546Left ventricular dimensions and prognosis in acute coronary syndromesP547Time course of myocardial alterations in a murine model of high fat diet: A strain rate imaging studyP548Subclinical left ventricular systolic dysfunction in patients with premature ventricular contractionsP549Global myocardial strain by CMR-based feature tracking (FT) and tagging to predict development of severe left ventricular systolic dysfunction after acute st-elevation myocardial infarctionP550Echocardiographic analysis of left and right ventricular function in patients after mitral valve reconstructionP551The role of regional longitudinal strain assessment in predicting response to cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and left bundle branch blockP552Speckle tracking automatic border detection improves echocardiographic evaluation of right ventricular systolic function in repaired tetralogy of fallot patients: comparison with MRI findingsP553Echocardiography: a reproducible and relevant tool in pah? intermediate results of the multicentric efort echogardiographic substudy (evaluation of prognostic factors and therapeutic targets in pah)Assessment of diastolic functionP554Relationship between left ventricular filling pressures and myocardial fibrosis in patients with uncomplicated arterial hypertensionP555Cardiac rehabilitation improves echocardiographic parameters of diastolic function in patients with ischemic heart diseaseP556Diastolic parameters in the calcified mitral annulusP557Biomarkers and echocardiography - combined weapon to diagnose and prognose heart failure with and without preserved ejection fractionP558Diastolic function changes of the maternal heart in twin and singleton pregnancyIschemic heart diseaseP559Syntax score as predictor for the correlation between epicardial adipose tissue and the severity of coronary lesions in patients with significant coronary diseaseP560Impact of strain analysis in ergonovine stress echocardiography for diagnosis vasospastic anginaP561Cardiac magnetic resonance tissue tracking: a novel method to predict infarct transmurality in acute myocardial infarctionP562Infarct size is correlated to global longitudinal strain but not left ventricular ejection fraction in the early stage of acute myocardial infarctionP563Magnetic resonance myocardial deformation assessment with tissue tracking and risk stratification in acute myocardial infarction patientsP564Increase in regional end-diastolic wall thickness by transthoracic echocardiography as a biomarker of successful reperfusion in anterior ST elevation acute myocardial infarctionP565Mitral regurgitation is associated with worse long-term prognosis in ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionP566Statistical significance of 3D motion and deformation indexes for the analysis of LAD infarctionHeart valve DiseasesP567Paradoxical low gradient aortic stenosis: echocardiographic progression from moderate to severe diseaseP568The beneficial effects of TAVI in mitral insufficiencyP569Impact of thoracic aortic calcification on the left ventricular hypertrophy and its regression after aortic valve replacement in patients with severe aortic stenosisP570Additional value of exercise-stress echocardiography in asymptomatic patients with aortic valve stenosisP571Valvulo-arterial impedance in severe aortic stenosis: a dual imaging modalities studyP572Left ventricular mechanics: novel tools to evaluate left ventricular performance in patients with aortic stenosisP573Comparison of long-term outcome after percutaneous mitral valvuloplasty versus mitral valve replacement in moderate to severe mitral stenosis with left ventricular dysfunctionP574Incidence of de novo left ventricular dysfunction in patient treated with aortic valve replacement for severe aortic regurgitationP575Transforming growth factor-beta dependant progression of the mitral valve prolapseP576Quantification of mitral regurgitation with multiple jets: in vitro validation of three-dimensional PISA techniqueP577Impaired pre-systolic contraction and saddle-shape deepening of mitral annulus contributes to atrial functional regurgitation: a three-dimensional echocardiographic studyP578Incidence and determinants of left ventricular (lv) reverse remodeling after MitraClip implantation in patients with moderate-to severe or severe mitral regurgitation and reduced lv ejection fractionP579Severe functional tricuspid regurgitation in rheumatic heart valve disease. New insights from 3D transthoracic echocardiographyP58015 years of evolution of the etiologic profile for prosthetic heart valve replacement through an echocardiography laboratoryP581The role of echocardiography in the differential diagnosis of prolonged fever of unknown originP582Predictive value for paravalvular regurgitation of 3-dimensional anatomic aortic annulus shape assessed by multidetector computed tomography post-transcatheter aortic valve replacementP583The significance and advantages of echo and CT imaging & measurement at transcatherter aortic valve implantation through the left common carotid accessP584Comparison of the self-expandable Medtronic CoreValve versus the balloon-expandable Edwards SAPIEN bioprostheses in high-risk patients undergoing transfemoral aortic valve implantationP585The impact of transcatheter aortic valve implantation on mitral regurgitation severityP586Echocardiographic follow up of children with valvular lesions secondary to rheumatic heart disease: Data from a prospective registryP587Valvular heart disease and different circadian blood pressure profilesCardiomyopathiesP588Comparison of transthoracic echocardiography versus cardiac magnetic for implantable cardioverter defibrillator therapy in primary prevention strategy dilated cardiomyopathy patientsP589Incidence and prognostic significance of left ventricle reverse remodeling in a cohort of patients with idiopathic dilated cardiomyopathyP590Early evaluation of diastolic function in fabry diseaseP591Echocardiographic predictors of atrial fibrillation development in hypertrophic cardiomyopathyP592Altered Torsion mechanics in patients with hypertrophic cardiomyopathy: LVOT-obstruction is the topdog?P593Prevention of sudden cardiac death in hypertrophic cardiomyopathy: what has changed in the guidelines?P594Coronary microcirculatory function as determinator of longitudinal systolic left ventricular function in hypertrophic cardiomyopathyP595Detection of subclinical myocardial dysfunction by tissue Doppler ehocardiography in patients with muscular dystrophiesP596Speckle tracking myocardial deformation analysis and three dimensional echocardiography for early detection of chemotherapy induced cardiac dysfunction in bone marrow transplantation patientsP597Left ventricular non compaction or hypertrabeculation: distinguishing between physiology and pathology in top-level athletesP598Role of multi modality imaging in familiar screening of Danon diseaseP599Early impairment of global longitudinal left ventricular systolic function independently predicts incident atrial fibrillation in type 2 diabetes mellitusP600Fetal cardiovascular programming in maternal diabetes mellitus and obesity: insights from deformation imagingP601Longitudinal strain stress echo evaluation of aged marginal donor hearts: feasibility in the Adonhers project.P602Echocardiographic evaluation of left ventricular size and function following heart transplantation - Gender mattersSystemic diseases and other conditionsP603The impact of septal kinetics on adverse ventricular-ventricular interactions in pulmonary stenosis and pulmonary arterial hypertensionP604Improvement in right ventricular mechanics after inhalation of iloprost in pulmonary hypertensionP605Does the treatment of patients with metabolic syndrome correct the right ventricular diastolic dysfunction?P606Predictors of altered cardiac function in breast cancer survivors who were treated with anthracycline-based therapyP607Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis: a prospective tissue-doppler echocardiography studyP608Diastolic and systolic left ventricle dysfunction presenting different prognostic implications in cardiac amyloidosisP609Diagnostic accuracy of Bedside Lung Ultrasonography in Emergency (BLUE) protocol for the diagnosis of pulmonary embolismP610Right ventricular systolic dysfunction and its incidence in breast cancer patients submitted to anthracycline therapyP611Right ventricular dysfunction is an independent predictor of survival among cirrhotic patients undergoing liver transplantCongenital heart diseaseP612Hypoplasia or absence of posterior leaflet: a rare congenital anomaly of the mitral valveP613ECHO screening for Barlow disease in proband's relativesDiseases of the aortaP614Aortic size distribution and prognosis in an unselected population of patients referred for standard transthoracic echocardiographyP615Abdominal aorta aneurysm ultrasonographic screening in a large cohort of asympromatic volounteers in an Italian urban settingP616Thoracic aortic aneurysm and left ventricular systolic functionStress echocardiographyP617Wall motion score index, systolic mitral annulus velocity and left ventricular mass predicted global longitudinal systolic strain in 238 patients examined by stress echocardiographyP618Prognostic parameters of exercise-induced severe mitral valve regurgitation and exercise-induced systolic pulmonary hypertensionP619Risk stratification after myocardial infarction: prognostic value of dobutamine stress echocardiographyP620relationship between LV and RV myocardial contractile reserve and metabolic parameters during incremental exercise and recovery in healthy children using 2-D strain analysisP621Increased peripheral extraction as a mechanism compensatory to reduced cardiac output in high risk heart failure patients with group 2 pulmonary hypertension and exercise oscillatory ventilationP622Can exercise induced changes in cardiac synchrony predict response to CRT?Transesophageal echocardiographyP623Fully-automated software for mitral valve assessment in chronic mitral regurgitation by three-dimensional transesophageal echocardiographyP624Real-time 3D transesophageal echocardiography provides more accurate orifice measurement in percutaneous transcatheter left atrial appendage closureP625Percutaneous closure of left atrial appendage: experience of 36 casesReal-time three-dimensional TEEP626Real-time three-dimensional transesophageal echocardiography during pulmonary vein cryoballoon ablation for atrial fibrilationP627Three dimensional ultrasound anatomy of intact mitral valve and in the case of type 2 disfunctionTissue Doppler and speckle trackingP629Left ventricle wall motion tracking from echocardiographic images by a non-rigid image registrationP630The first experience with the new prototype of a robotic system for remote echocardiographyP631Non-invasive PCWP influence on a loop diuretics regimen monitoring model in ADHF patients.P632Normal range of left ventricular strain, dimensions and ejection fraction using three-dimensional speckle-tracking echocardiography in neonatesP633Circumferential ascending aortic strain: new parameter in the assessment of arterial stiffness in systemic hypertensionP634Aortic vascular properties in pediatric osteogenesis imperfecta: a two-dimensional echocardiography derived aortic strain studyP635Assessment of cardiac functions in children with sickle cell anemia: doppler tissue imaging studyP636Assessment of left ventricular function in type 1 diabetes mellitus patients by two-dimensional speckle tracking echocardiography: relation to duration and control of diabetesP637A study of left ventricular torsion in l-loop ventricles using speckle-tracking echocardiographyP638Despite No-Reflow, global and regional longitudinal strains assessed by two-dimensional speckle tracking echocardiography are predictive indexes of left ventricular remodeling in patients with STEMIP639The function of reservoir of the left atrium in patients with medicaly treated arterial hypertensionP640The usefulness of speckle tracking analysis for predicting the recovery of regional systolic function after myocardial infarctionP641Two dimensional speckle tracking echocardiography in assessment of left ventricular systolic function in patients with rheumatic severe mitral regurgitation and normal ejection fractionP642The prediction of left-main and tripple vessel coronary artery disease by tissue doppler based longitudinal strain and strain rate imagingP643Role of speckle tracking in predicting arrhythmic risk and occurrence of appropriate implantable defibrillator Intervention in patients with ischemic and non-ischemic cardiomyopathyComputed Tomography & Nuclear CardiologyP644Cardiac adrenergic activity in patients with nonischemic dilated cardiomyopathy. Correlation with echocardiographyP645Different vascular territories and myocardial ischemia, there is a gradient of association? Eur Heart J Cardiovasc Imaging 2015. [DOI: 10.1093/ehjci/jev278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
200
|
Urena M, Himbert D, Rodés-Cabau J, Vahanian A. Percutaneous aortic valve interventions in heart failure patients. Minerva Cardioangiol 2015; 63:547-561. [PMID: 26397947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The onset of symptoms of heart failure is a landmark in the natural history of aortic stenosis, and is associated with a dramatic reduction in survival. Aortic valve replacement markedly increases life-expectancy in such patients. However, the presence of heart failure and/or left ventricular dysfunction are strong predictors of poor acute and late mortality after cardiac surgery and the most frequent conditions leading to deny surgical aortic valve replacement in elderly patients. The last decade has witnessed the development of transcatheter aortic valve implantation (TAVI) and, consequently, the resurgence of percutaneous balloon aortic valvuloplasty (PBAV) and, both, are currently routine therapy for high-risk patients. These minimally invasive procedures are appealing therapeutic options for the subset of patients with heart failure and or/left ventricular systolic dysfunction. The available evidence on the results of PBAV and TAVI therapies in this setting is discussed and a management strategy is proposed.
Collapse
Affiliation(s)
- M Urena
- Bichat Claude Bernard Hospital, Paris VII University, Paris, France -
| | | | | | | |
Collapse
|